During an annual survey, the following deficient practice was an Immediate Jeopardy was found: On 07/09/18, a nurse gave R #185 [MEDICATION NAME] (an anti-psychotic) PRN order for sleep. The resident and his wife report that on the next day, he was over sedated. The resident further reported that he an anxious about getting his medication. This resulted in an Immediate Jeopardy that was called on 07/11/18 at 6:49 pm. A acceptable Plan of Removal was submitted on 07/27/18 at 11:00 am and approved. The plan was: MD was writing orders for anti-psychotic for PRN for sleep. The Nurse did not seek clarification from the MD prior to giving the medication. * Interventions: A. …
F758 citations in New Mexico
Psychotropic drugs · Pharmacy Service Deficiencies
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated, prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic medications are only used when the medication is necessary and PRN use is limited.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
New Mexico cites F758 less often than its own record predicts
0.85 times the national share — cited less often here than elsewhere.
Of every deficiency written in New Mexico in 2025, this is the portion that was F758.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What New Mexico surveyors wrote
F758 findings written in New Mexico, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
Based on record review and interview, the facility failed to keep residents free from psychotropic medications (any drug that affects brain activities associated with mental processes and behavior) for 2 (R #45 and R #46) of 5 (R #9, R #45, R #46, R #62 and R #90) residents reviewed for unnecessary medications when they failed to: 1. Carry out a gradual dose reduction (GDR; stepwise tapering of a dose to determine if symptoms, conditions, or risks can be managed by a lower dose or if the medication can be discontinued) and failed to document clinical rationale to continue psychotropic medications for R #45 and R #46. 2. …
The short window
Recent years
| Year | Share of New Mexico citations | vs expected |
|---|---|---|
| 2023 | 1.84% | 1.11× |
| 2024 | 1.75% | 1.18× |
| 2025 | 0.54% | 0.85× |
Shares of citations, not counts: earlier years hold fewer inspections.
What else New Mexico surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction